Target intelligence / Profile preview

Henipavirus fusion glycoprotein (F protein) (F protein)

Target
F protein
Molecular classification
Viral surface protein, Class I viral fusion protein
01

Overview

The Henipavirus fusion (F) glycoprotein is a critical structural component of Hendra virus (HeV) and Nipah virus (NiV), two highly pathogenic zoonotic viruses (UniProt: P0C1C6). As a class I viral fusion protein, it facilitates the merging of the viral envelope with the host cell membrane, a process essential for viral entry and subsequent infection (PMID: 22438551). The F protein is synthesized as an inactive precursor, F0, which requires proteolytic cleavage by host cell enzymes, such as cathepsin L, to become fusion-competent. It functions in a coordinated manner with the attachment (G) glycoprotein; once the G protein binds to host receptors (ephrin-B2 or ephrin-B3), the F protein undergoes a dramatic conformational change to drive membrane fusion (PMID: 30305457). Because of its indispensable role in the viral life cycle, the F protein is a primary target for the development of therapeutic interventions, including neutralizing monoclonal antibodies like 5B3 and fusion-inhibitory peptides derived from the HR2 domain. Inhibiting this protein prevents the virus from delivering its genetic material into the host cytoplasm, thereby halting the infection process and preventing the formation of multinucleated syncytia.

Other names
Hendra virus fusion proteinNipah virus fusion proteinHeV-FNiV-FFusion glycoprotein F0Protein F
02

Mechanism of action

Inhibition of viral-host membrane fusion by preventing the conformational transition of the F protein from a pre-fusion to a post-fusion state.

03

Biological functions

Viral entryMembrane fusionSyncytia formation
04

Disease associations

Hendra virus infectionNipah virus infectionEncephalitisSevere respiratory illness
05

Safety considerations

High viral mutation rateRequirement for BSL-4 containment for studyPotential for antibody-dependent enhancement (ADE)
06

Interacting drugs

HR2-derived peptides

3 more in the full profile.

07

Biomarkers

Viral RNA (RT-PCR)F-protein specific IgG/IgMNeutralizing antibody titers

Beyond the preview

Go deeper on Henipavirus fusion glycoprotein (F protein) (F protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Henipavirus fusion glycoprotein (F protein) (F protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call